United Kingdom · Biotechnology startup
United Kingdom · Myricx Bio
Myricx Bio is a biotechnology company that develops novel NMT inhibitor payloads for ADCs to treat cancer.
Funding reportedLast round: Series A
What company datasets say Myricx Bio raised
Funding, as reported
Reported in all115.3Min the source's currency
Rounds2
Last roundSeries A
Last round dateJul 2024
Investors listed7
Biotechnology in United Kingdom
Startups like it
F2GManchester · founded 1998
COMPASS PathwaysAltrincham · founded 2016- IdrxLondon · founded 2022
PepgenOxford · founded 2018
Beckley PsytechBeckley · founded 2019
Cambridge EpigenetixChesterford Research Park · founded 2012
Ascend Gene And Cell Therapies Ltd.Altrincham · founded 2021
Green BiologicsAbingdon · founded 2003
Is this your company?
Add your raise, your deck and your story, and put Myricx Bio in front of investors. Or tell us what we have wrong.